ENSC - Company ID 0001716947
Ensysce Biosciences, Inc. (ENSC) reported net income of -$10.18M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$10.18M | -27.4% |
| FY 2024 | -$7.99M | +24.8% |
| FY 2023 | -$10.63M | -346.5% |
| FY 2020 | $4.31M | +503.9% |
| FY 2019 | -$1.07M | -150.3% |
| FY 2018 | $2.12M | - |
Ensysce Biosciences, Inc. (ENSC) reported net income of -$10.18M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2018 and fiscal 2025, Ensysce Biosciences, Inc.'s net income declined from $2.12M to -$10.18M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.